Fisher & Paykel Healthcare Corporation Limited logo

FPH Updates Release Date for Full Year Results

Full Year Results5 April 2020FPHHealthcare

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


Fisher & Paykel Healthcare updates release date for full year results


Auckland, New Zealand, 6 April 2020 - Fisher & Paykel Healthcare Corporation Limited advises

that the company’s results for the year ended 31 March 2020 will be released on Monday,

29 June 2020, instead of Thursday, 28 May 2020, as previously advised.


This announcement has been made in reliance on the NZX class waiver dated 19 March 2020,

which provides listed companies with an additional 30 days to prepare and release their full

year results, and an additional two months to prepare and deliver their annual reports.


Fisher & Paykel Healthcare Corporation Limited intends to release its annual report together

with its financial results on Monday, 29 June 2020 and, accordingly, as at the date of this

announcement, does not intend to rely on the NZX class waiver with respect to the publication

of its annual report.


“At the present time, we have nearly 5,000 people around the world who are focussed on

meeting the increased demand for our respiratory products, which are being used in the

treatment of patients with COVID-19,” said Chief Financial Officer Lyndal York.


“This time of year our financial controllers in our global offices would usually be dedicated to

completing year end reporting. Because of the COVID-19 pandemic, many of these people are

currently working remotely – assisting with customer enquiries, getting product into the hands of

customers and providing operational support.”


“One of our core beliefs is doing what is best for the patient, and it should come as no surprise

that we think that these activities should take priority,” said Mrs York.



About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and

systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep

apnea. The company’s products are sold in over 120 countries worldwide. For more information

about the company, visit our website www.fphcare.com.


Ends


Media & Investor Contacts:

Karen Knott

Senior Communications Manager

karen.knott@fphcare.co.nz

+64 (0) 21 713 911

Hayden Brown

Investor Relations Manager

hayden.brown@fphcare.co.nz

+64 (0) 27 807 8073



Authorised by:

Lyndal York

Chief Financial Officer.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.